Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis
A Prospective, Multicenter, Registry Study to Evaluate the Safety, Efficacy, and Standardized Procedural Optimization of the Intracranial Drug-Eluting Stent System in Patients with Symptomatic Intracranial Atherosclerotic Stenosis
Sponsor: Sino Medical Sciences Technology Inc.
This NA trial investigates Intracranial Atherosclerotic Stenosis and is currently actively recruiting participants. Sino Medical Sciences Technology Inc. leads this study, which shows 2 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
2 versions recorded-
May 2025 — Present [monthly]
Recruiting NA
-
Apr 2025 — May 2025 [monthly]
Recruiting NA
First recorded
Mar 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sino Medical Sciences Technology Inc.
- The First Affiliated Hospital of Zhengzhou University
- Tongji Hospital
For direct contact, visit the study record on ClinicalTrials.gov .